PATH
GlucosePATH was developed based on a common interest between a physician and a computer scientist to help patients find affordable and effective treatments for Type 2 Diabetes Mellitus. Through this process, GlucosePATH have found that the computational tools used in the travel and finance industry can be leveraged to help clinicians and patients.
PATH
Social Links:
Industry:
Clinical Trials Health Care Software
Address:
Orlando, Florida, United States
Country:
United States
Website Url:
http://www.glucosepath.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Content Delivery Network Mobile Non Scaleable Content Amazon Google Apps For Business JsDelivr
Similar Organizations
AiCure
AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Thea Health
Thea Health improves communication between primary care physicians and specialists for a better healthcare experience for patients.
Official Site Inspections
http://www.glucosepath.com
- Host name: ec2-15-205-186-148.us-gov-west-1.compute.amazonaws.com
- IP address: 15.205.186.148
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "PATH"
PATH
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds.See details»
Whatโs a Fair Price to Pay for a Medicine? - glucosepath.com
At the 2018 American Diabetes Association conference, we presented two posters showing how you can use GlucosePATH to determine a fair price to pay for two new Type 2 Diabetes โฆSee details»
Contact Us - PATH
Contact Us Thank you for your interest. Let us know how we can help you.See details»
PATH - Crunchbase Company Profile & Funding
GlucosePATH was developed based on a common interest between a physician and a computer scientist to help patients effective treatments.See details»
GlucosePATH - 2025 Company Profile & Competitors - Tracxn
Apr 23, 2025 GlucosePATH is an unfunded company based in Celebration (United States), founded in 2016 by Bradley Eilerman. It operates as a Provider of personalized type 2 โฆSee details»
FAQ - PATH
GlucosePATH evaluates all possible combinations of medications for a given patient's data, using five criteria: A1c Reduction, Cost, Weight Change, Side Effects, and Likely Adherence. โฆSee details»
The Diabetes Treatment Lottery - GlucosePATH โฆ
Jan 19, 2019 The GlucosePATH decision support software was designed to help patients and providers make practical scientific and economic health decision at the bedside.See details»
FINAL REPORT: - Diabetes In Control
Clinical Decision-Support Software uct named GlucosePATH. The application is not integrated within the EHR system, thereby requiring separate workflow for its use. The software is โฆSee details»
Transforming Diabetes Care: GlucosePATH Makes โฆ
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by computer scientist Len Testa and โฆSee details»
Transforming Diabetes Care: GlucosePATH Makes Personalized
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It โฆSee details»
Software Price Modeling of Semaglutide - American Diabetes โฆ
Jul 1, 2018 GlucosePATH is a clinically validated decision support system which creates drug regimens for patients with type 2 diabetes. Regimens are optimized for HbA1c, weight, side โฆSee details»
DIABETES CONNECTIONS TYPE 2
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It โฆSee details»
PATH
GlucosePATHโs software considers all 6 million different treatment options for each patient, using the patientโs medical data, insurance coverage, and monthly budget.See details»
Presentation - Diabetes In Control
Treatment Recommendations GlucosePATH will recommend up to 10 distinct treatment regimens. Most regimens have different HbA1c, cost, weight change, or side-effect changes. โฆSee details»
Kentucky Diabetes Patients: Can Artificial Intelligence Tool โฆ
Oct 6, 2020 GlucosePATH equips physicians with various treatment options for patients with type 2 diabetes by curating their particular needs and integrating the medication cost into the โฆSee details»
Sign up - PATH2
Nov 16, 2018 PATH Decision Support Software LLC (โ PATH Software,โ โ we,โ โ us,โ or โ our โ) oversees this website, including the services underlying the site and the content appearing โฆSee details»
AI Tool Improves Outcomes for Type 2 Diabetes Patients
Oct 10, 2020 The project design consisted of using an electronic tool (www.GlucosePath.com) to facilitate and recommend treatments to patients based on cost and social factors. The project โฆSee details»
GlucosePath Software - Point-Counterpoint on Using AI in Diabetes
May 5, 2020 Information about GlucosePATH software that can go through over 6 million possible treatments using anywhere from 1 to 5 drugs for type 2 diabetes.See details»
Log in - glucosepath.com
PasswordSign up Forgot your password or username?See details»
GlucoPath Claims to Balance Blood SugarโBut Does It Really Work?
Feb 7, 2025 In todayโs fast-paced world, maintaining healthy blood sugar levels is crucial for overall well-being, particularly for those facing the challenges of type 2 diabetes. This condition โฆSee details»